Sciomics

🌍 𝗪𝗵𝗮𝘁 𝗱𝗿𝗶𝘃𝗲𝘀 𝘁𝗵𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝗳𝗶𝗴𝗵𝘁 𝗮𝗴𝗮𝗶𝗻𝘀𝘁 𝗽𝗮𝗻𝗰𝗿𝗲𝗮𝘁𝗶𝗰 𝗰𝗮𝗻𝗰𝗲𝗿? 💜 On this 𝗪𝗼𝗿𝗹𝗱 𝗣𝗮𝗻𝗰𝗿𝗲𝗮𝘁𝗶𝗰 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆, the 𝗦𝗰𝗶𝗼𝗺𝗶𝗰𝘀 𝘁𝗲𝗮𝗺 𝗮𝗽𝗽𝗿𝗲𝗰𝗶𝗮𝘁𝗲𝘀 the dedication and efforts of the global research community in uncovering the molecular mechanisms behind one of the most challenging cancers to detect and treat. Pancreatic cancer often presents late, making 𝗲𝗮𝗿𝗹𝘆 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 and 𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 critical goals for the patients and research community. From studying its fundamental molecular mechanisms to advancing diagnostics and therapeutics, every discovery brings potential new avenues of treatment and better outcome to patients and their families. 🔬 At Sciomics, we are proud to support these efforts through our 𝗵𝗶𝗴𝗵-𝘁𝗵𝗿𝗼𝘂𝗴𝗵𝗽𝘂𝘁 𝗽𝗿𝗼𝘁𝗲𝗶𝗻 𝗮𝗻𝗱 𝗽𝗼𝘀𝘁-𝘁𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗺𝗼𝗱𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 (𝗣𝗧𝗠) 𝗽𝗿𝗼𝗳𝗶𝗹𝗶𝗻𝗴 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺, enabling biomarker discovery and advancing Precision Medicine. 👩🔬 👨🔬 Let’s work together toward a better future for those affected by pancreatic cancer. #WorldPancreaticCancerDay #PancreaticCancer #CancerResearch #PrecisionMedicine #Sciomics #Proteomics

🌍 𝗪𝗼𝗿𝗹𝗱 𝗗𝗶𝗮𝗯𝗲𝘁𝗲𝘀 𝗗𝗮𝘆 𝟮𝟬𝟮𝟰: 𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗕𝗮𝗿𝗿𝗶𝗲𝗿𝘀, 𝗕𝗿𝗶𝗱𝗴𝗶𝗻𝗴 𝗚𝗮𝗽𝘀 💙 On 𝗪𝗼𝗿𝗹𝗱 𝗗𝗶𝗮𝗯𝗲𝘁𝗲𝘀 𝗗𝗮𝘆, we at 𝗦𝗰𝗶𝗼𝗺𝗶𝗰𝘀 𝗚𝗺𝗯𝗛 reflect on the profound impact of diabetes research and our contributions toward advancing science for better patient outcomes. We work with partners from academia and biotech to discover 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀 and to understand the 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗺𝗲𝗰𝗵𝗮𝗻𝗶𝘀𝗺𝘀 underlying diabetes and its complications, including its relationship with cancer, neurodegenerative diseases, and other metabolic diseases. 🔬 In recent years, the 𝗦𝗰𝗶𝗼𝗺𝗶𝗰𝘀 𝘁𝗲𝗮𝗺 contributed to a study titled "𝗖𝗵𝗮𝗻𝗴𝗲𝘀 𝗶𝗻 𝗽𝗿𝗼𝘁𝗲𝗶𝗻 𝗲𝘅𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗱𝘂𝗲 𝘁𝗼 𝗺𝗲𝘁𝗳𝗼𝗿𝗺𝗶𝗻 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗵𝘆𝗽𝗲𝗿𝗶𝗻𝘀𝘂𝗹𝗶𝗻𝗲𝗺𝗶𝗮 𝗶𝗻 𝗮 𝗵𝘂𝗺𝗮𝗻 𝗲𝗻𝗱𝗼𝗺𝗲𝘁𝗿𝗶𝗮𝗹 𝗰𝗮𝗻𝗰𝗲𝗿 𝗰𝗲𝗹𝗹 𝗹𝗶𝗻𝗲". This research explored how metformin, a commonly prescribed medication for type II diabetes mellitus, influences protein expression in cancer cells, particularly in the context of hyperinsulinemia – a condition commonly seen in diabetic patients. 👩🔬 👨🔬 Through our 𝘀𝗰𝗶𝗼𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 antibody microarray service, we helped to uncover key insights into how metformin may counteract some of the pro-cancerous effects induced by high insulin levels. These findings bring us closer to understanding how diabetes treatments can play a role not only in managing diabetes but also in preventing or treating associated conditions, such as endometrial cancer. Carsten Lange | Amanda Machado Weber | Ronny Schmidt | Dr. Christoph Schröder | Thomas Strowitzki | Ariane Prof. Dr. Germeyer   #WorldDiabetesDay #DiabetesAwareness #DiabetesResearch #Sciomics #Proteomics #HealthcareInnovation

🔬 We’re excited to be at #BIOEurope in Stockholm! BIO Europe is in full swing, and we’re ready to connect. Join us at booth 180-04 in the German Pavilion or book a partnering meeting to discuss our innovative biomarker pipeline and comprehensive protein profiling services tailored for preclinical research. Our CEO, Christoph Schröder, is here to meet and explore collaboration opportunities with you! See you there! 👋 #BIOEurope2024 #Biomarkers #ProteinProfiling #Sciomics #LifeSciences

🌟 𝗕𝗮𝗰𝗸 𝗳𝗿𝗼𝗺 𝗞𝗶𝗱𝗻𝗲𝘆 𝗪𝗲𝗲𝗸 𝟮𝟬𝟮𝟰 – 𝗜𝗻𝘀𝗽𝗶𝗿𝗲𝗱 𝗯𝘆 𝗡𝗲𝘄 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗮𝗻𝗱 𝗖𝗼𝗻𝗻𝗲𝗰𝘁𝗶𝗼𝗻𝘀 🌟 ✈️ We have returned from San Diego, where Anne Griesbeck, Manfred Scholz, and Dr. Christoph Schröder attended the 𝗔𝗦𝗡 𝗞𝗶𝗱𝗻𝗲𝘆 𝗪𝗲𝗲𝗸 𝟮𝟬𝟮𝟰. This event was an incredible opportunity to explore the latest advancements in kidney research, diagnostics, and treatment innovations. We were thrilled by the countless opportunities to connect with 𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝗲𝘅𝗽𝗲𝗿𝘁𝘀 𝗶𝗻 𝗻𝗲𝗽𝗵𝗿𝗼𝗹𝗼𝗴𝘆 and discuss our work on a biomarker panel aimed at the 𝗲𝗮𝗿𝗹𝘆 𝗮𝗻𝗱 𝗽𝗿𝗲𝗰𝗶𝘀𝗲 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 of 𝗔𝗰𝘂𝘁𝗲 𝗞𝗶𝗱𝗻𝗲𝘆 𝗜𝗻𝗷𝘂𝗿𝘆 (𝗔𝗞𝗜). 👩🔬 👨🔬 Connect with us and follow us on our journey to develop a 𝗯𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝘁𝗼𝗼𝗹 for Acute Kidney Injury! We are excited about what lies ahead! #KidneyWeek2024 #AcuteKidneyInjury #Nephrology #Diagnostics #AKI #DiagnosticInnovation #Innovation #Networking #Sciomics

🌟 Exciting times at #KidneyWeek! 🌟 The scioDx team is in San Diego for ASN Kidney Week, eager to connect and discuss our work on a biomarker panel for the early and precise diagnosis of Acute Kidney Injury (AKI). We’re inspired by the groundbreaking science here and look forward to exchanging insights with fellow experts and advancing the future of kidney health together. If you’re here, we’d love to meet up and chat! #AKI #Biomarkers #ASN #KidneyWeek2024

🌟 𝗢𝘂𝗿 𝗷𝗼𝘂𝗿𝗻𝗲𝘆 𝘁𝗼 𝗱𝗲𝘃𝗲𝗹𝗼𝗽 𝗮 𝗯𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝘁𝗼𝗼𝗹 𝗳𝗼𝗿 𝗔𝗰𝘂𝘁𝗲 𝗞𝗶𝗱𝗻𝗲𝘆 𝗜𝗻𝗷𝘂𝗿𝘆 (𝗔𝗞𝗜) 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲𝘀! 🌟 ✈️ We are on our way to 𝗦𝗮𝗻 𝗗𝗶𝗲𝗴𝗼 for 𝗞𝗶𝗱𝗻𝗲𝘆 𝗪𝗲𝗲𝗸 𝟮𝟬𝟮𝟰! Our colleagues Anne Griesbeck and Dr. Christoph Schröder are excited to gain new insights and engage in discussions with the kidney research community. 👩🔬 👨🔬 At Sciomics, we have dedicated significant effort to identifying biomarkers for the early detection of 𝗔𝗰𝘂𝘁𝗲 𝗞𝗶𝗱𝗻𝗲𝘆 𝗜𝗻𝗷𝘂𝗿𝘆 (𝗔𝗞𝗜). During Kidney Week, we look forward to 𝗲𝘅𝗽𝗮𝗻𝗱𝗶𝗻𝗴 𝗼𝘂𝗿 𝗻𝗲𝘁𝘄𝗼𝗿𝗸 and finding 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀 to help develop a reliable diagnostic test that can detect this common complication 𝘁𝘄𝗼 𝗱𝗮𝘆𝘀 𝗲𝗮𝗿𝗹𝗶𝗲𝗿 than the current clinical gold standard. 🤝 If you are attending Kidney Week and would like to connect, please reach out to Anne and Christoph! 🌎  𝗦𝗮𝗳𝗲 𝘁𝗿𝗮𝘃𝗲𝗹𝘀 𝘁𝗼 𝗮𝗹𝗹 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝗻𝘁𝘀 𝗮𝗻𝗱 𝘄𝗲 𝗹𝗼𝗼𝗸 𝗳𝗼𝗿𝘄𝗮𝗿𝗱 𝘁𝗼 𝘀𝗲𝗲𝗶𝗻𝗴 𝘆𝗼𝘂 𝗶𝗻 𝗦𝗮𝗻 𝗗𝗶𝗲𝗴𝗼! 🌎 #KidneyWeek2024 #AcuteKidneyInjury #Diagnostics #AKI #DiagnosticInnovation #Innovation #Networking #Sciomics American Society of Nephrology

🚀 𝗧𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗻𝗴 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗟𝗮𝗯 𝘁𝗼 𝘁𝗵𝗲 𝗖𝗹𝗶𝗻𝗶𝗰 🚀 Exciting day at the 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗼𝗿𝘀’ 𝗗𝗮𝘆 𝟮𝟬𝟮𝟰, organized by the BioRN Life Science Cluster Rhine-Neckar. Our colleagues Barbara Eberbach and Dr. Christoph Schröder just pitched our 𝗴𝗿𝗼𝘂𝗻𝗱𝗯𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 - a precise diagnostic test for 𝗔𝗰𝘂𝘁𝗲 𝗞𝗶𝗱𝗻𝗲𝘆 𝗜𝗻𝗷𝘂𝗿𝘆 (𝗔𝗞𝗜) that will detect this common complication 𝘁𝘄𝗼 𝗱𝗮𝘆𝘀 𝗲𝗮𝗿𝗹𝗶𝗲𝗿 than the current clinical gold standard. 👩🔬 👨🔬 The development of this diagnostic test is based on biomarkers identified through our scioDiscover platform, demonstrating the successful translation of microarray-based research into clinical application. We are actively seeking 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀 to bring this innovative test to market and make a real difference in patient outcomes. Let's push innovation forward! 🤝 #LifeScience #Diagnostics #AcuteKidneyInjury #AKI #Sciomics #Innovation #InvestInHealth #BioRN #Biomarkers #EarlyDetection

🌍 𝗪𝗼𝗿𝗹𝗱 𝗠𝗲𝗻𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗗𝗮𝘆 𝟮𝟬𝟮𝟰: 𝗕𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝗮 𝗛𝗲𝗮𝗹𝘁𝗵𝗶𝗲𝗿 𝗮𝗻𝗱 𝗛𝗮𝗽𝗽𝗶𝗲𝗿 𝗪𝗼𝗿𝗸𝗽𝗹𝗮𝗰𝗲 𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿 💚 👩🔬 👨🔬 At Sciomics, we believe that mental health is just as critical as physical health in maintaining a thriving, productive, and innovative workplace. On World Mental Health Day, we reaffirm our commitment to fostering an environment that promotes psychological well-being, understanding, and support. 🔬 🧠 Whether you are working as a scientist in cutting-edge research or contributing behind the scenes, mental health impacts everyone. It is our collective responsibility to destigmatize mental health challenges, encourage open conversations, and support one another. Remember: You are not alone, and seeking help is a sign of strength. #WorldMentalHealthDay #MentalHealth #MentalHealthMatters #EmployeeWellbeing #Sciomics

🌟 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗗𝗮𝘆 𝗮𝘁 𝘁𝗵𝗲 𝗕𝗶𝗼𝗥𝗡 𝗔𝗻𝗻𝘂𝗮𝗹 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝟮𝟬𝟮𝟰! 🌟 👩🔬 👨🔬 The Sciomics team is proud to participate in the BioRN Annual Conference 2024, hosted by the BioRN Life Science Cluster. Meet our colleagues Dr. Christoph Schröder and Ronny Schmidt at the new Heidelberg Congress Center. 🔬 This year’s focus on 𝗻𝗲𝘄 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗺𝗼𝗱𝗮𝗹𝗶𝘁𝗶𝗲𝘀 𝗶𝗻 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 aligns perfectly with our mission to advance 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 and 𝗽𝗿𝗼𝘁𝗲𝗼𝗺𝗶𝗰𝘀. Christoph and Ronny are excited to gain new insights and exchange ideas, exploring how we can drive the future of personalized healthcare together. We look forward to fostering meaningful collaborations with both new and longstanding partners! 🤝 #BioRNAnnualConference2024 #BioRN #PersonalizedMedicine #PrecisionMedicine #LifeScience #Sciomics #Proteomics #Collaboration #HeidelbergCongressCenter

We are excited to attend the 𝗕𝗶𝗼𝗥𝗡 𝗔𝗻𝗻𝘂𝗮𝗹 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 and explore the latest insights in 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 and beyond. Meet Ronny Schmidt and Dr. Christoph Schröder on October 9. Registration is still open: https://lnkd.in/dQvysUw